MedTrace Logo

Follow-up Using Patient-Reported Outcome (PRO) Measures in Patients With Chronic Kidney Disease

NCT03847766 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 152

Last updated 2023-12-22

No results posted yet for this study

Summary

This randomized controlled trial (RCT) will evaluate if PRO-based follow-up is at least as effective as usual outpatient follow-up in managing decline in renal function and maintaining patients' quality of life. Furthermore, we intend to characterize the target patient group that is suitable for PRO-based follow up in a group of patients suffering from renal insufficiency.

Conditions

  • Chronic Kidney Diseases

Interventions

BEHAVIORAL

PRO-based follow-up

Diagnose specific questionnaires are used to screen patients in need of contact to the outpatient clinic

BEHAVIORAL

PRO-based telephone consultation

diagnose-specific questionnaires are used to support communication between clinician and patient during a phone consultation

Sponsors & Collaborators

  • Regional Hospital West Jutland

    collaborator OTHER

  • Aarhus University Hospital

    collaborator OTHER

  • TrygFonden, Denmark

    collaborator INDUSTRY

  • Karen Elise Jensen Foundation

    collaborator OTHER

  • Sygekassernes Helsefond

    collaborator OTHER

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Niels Henrik Hjollund, MD,Professor · Regional Hospital West Jutland

  • Birgith Grove, MHSc · Aarhus University Hospital & Regional Hospital West Jutland

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-03
Primary Completion
2023-12-15
Completion
2023-12-15

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03847766 on ClinicalTrials.gov